After numerous attempts, the PD-1/PD-L1 inhibitors were proved to have the ability to remove the coinhibitory signal by blocking PD-1 or PD-L1, and rebuild the normal immune system surveillance kill tumor cells (Sharma and Allison, 2015). Here, CD274 is linked to neoplasm.